In a Swedish sample, higher plasma copeptin (as a surrogate marker of AVP) concentrations were associated with higher prevalence of T2D and insulin resistance, both cross-sectionally and longitudinally [12]. The gene discussed is AVP; the disease is Insulin resistance.